MM MBRACE THERAPEUTICS Trademark
Trademark Overview
On Friday, January 26, 2024, a trademark application was filed for MM MBRACE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MM MBRACE THERAPEUTICS trademark a serial number of 98378002. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by MBrace Therapeutics, Inc.. The MM MBRACE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors
Antibody testing for medical diagnostic or treatment purposes
General Information
Serial Number | 98378002 |
Word Mark | MM MBRACE THERAPEUTICS |
Filing Date | Friday, January 26, 2024 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, November 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, October 1, 2024 |
Trademark Statements
Description of Mark | The mark consists of mirroring "MM" design within circular carrier element to the left of the word "MBRACE" in stylized font. Below the word "MBRACE" is the word "THERAPEUTICS" in stylized font. |
Goods and Services | Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Antibody testing for medical diagnostic or treatment purposes |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 12, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 12, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | MBrace Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | San Diego, CA 92121 |
Party Name | MBrace Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | San Diego, CA 92121 |
Trademark Events
Event Date | Event Description |
Tuesday, January 30, 2024 | NEW APPLICATION ENTERED |
Monday, February 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 13, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, August 22, 2024 | ASSIGNED TO EXAMINER |
Friday, August 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, August 23, 2024 | NON-FINAL ACTION WRITTEN |
Friday, August 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, August 23, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 1, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, October 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |